Chinese humanoid robot maker Unitree prices IPO at $9 billion valuation
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel is largely bearish on Unitree's IPO, citing a frothy valuation, margin compression, and significant geopolitical risks, despite the potential of AI and software integration.
Risk: Forced tech-sharing or margin caps due to Beijing's subsidies, which could structurally impair Unitree's path to high margins.
Opportunity: The potential integration of DeepSeek's LLMs into Unitree's OS, which could decouple them from traditional robotics margins and create a software moat.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
BEIJING/SHANGHAI/SINGAPORE, Aug 6 (Reuters) - China's Unitree has priced its Shanghai initial public offering at 150.8 yuan ($22.34) per share, valuing the company at around 61 billion yuan ($9.04 billion), it said on Thursday, in a deal that would make it the country's first mainland-listed maker of humanoid robots.
In a filing to the Shanghai Stock Exchange, Unitree, also known as Yushu Technology, said it was seeking to raise 6.1 billion yuan. The potential valuation at the time of listing is above an earlier target of up to 50 billion yuan reported by Reuters in September.
The IPO comes as the United States and China ratchet up trade and technology tensions, with Washington tightening Chinese access to U.S. technology and markets - including the imposition of new restrictions on foreign-made humanoid and four-legged robots - and Beijing responding with export curbs and sanctions on selected U.S. entities.
Unitree has said its existing humanoid and four-legged robots, known for their running, dancing and acrobatic displays, have U.S. approvals, but future models could be barred from sale there.
The Hangzhou-based company is selling 40.45 million new shares, or 10% of its enlarged share capital, on Shanghai's STAR Market, according to its sale prospectus.
Chinese AI company DeepSeek is among the strategic investors in Unitree's IPO, according to Thursday's filing.
IPO subscriptions are due to open on August 10 and Unitree plans to use the proceeds to develop robot software and hardware, launch new products and build a manufacturing base, the prospectus showed.
U.S. SALES RISK
U.S. sales accounted for 13.3% of Unitree's revenue last year, according to the prospectus. It said that U.S. tariffs, limits on government purchases, export controls or the loss of existing approvals could hurt overseas growth and disrupt supplies of imported parts.
Overall revenue more than quadrupled to 1.7 billion yuan in 2025 with humanoid robots generating 867.8 million yuan in sales and overtaking four-legged robots as Unitree's largest business, according to the prospectus.
But growth has slowed this year. First-quarter revenue rose 68.5% to 422.8 million yuan, but profit excluding one-off items fell 52.6% to 40.3 million yuan as Unitree increased spending on research and marketing.
($1 = 6.7488 Chinese yuan renminbi)
(Reporting by Beijing Newsroom, Samuel Shen in Shanghai and Yantoultra Ngui in Singapore; Editing by Louise Heavens, Kirsten Donovan)
Four leading AI models discuss this article
"Unitree's $9B IPO valuation already discounts most optimistic China-centric growth while glossing over margin erosion, U.S. revenue risk, and unproven software scalability."
Unitree's $9B IPO valuation prices in explosive growth after 2025 revenue quadrupled to 1.7B yuan, with humanoids overtaking quadrupeds. Yet Q1 2026 already shows deceleration: revenue +68% but adjusted profit -53% amid rising R&D/marketing spend. U.S. exposure (13% of sales) faces fresh export curbs and potential loss of approvals, while Beijing's own tech nationalism adds reciprocal risk. At ~36x trailing sales the deal looks frothy for a hardware-heavy story still burning cash on prototypes. STAR Market liquidity and strategic investor DeepSeek provide tailwinds, but execution risk on software monetization is high.
If China successfully decouples its robotics supply chain and domestic demand (factories, eldercare, military) explodes, Unitree could re-rate to 15-20x sales within 24 months, rendering today's $9B look cheap; the article underplays Beijing's willingness to subsidize national champions in strategic tech.
"The company’s extreme price-to-sales multiple is fundamentally disconnected from the reality of its shrinking margins and the high probability of losing its U.S. market access."
Unitree’s $9 billion valuation on a 1.7 billion yuan revenue base implies a price-to-sales ratio exceeding 35x, a massive premium for a hardware-centric firm facing significant geopolitical headwinds. While the shift from quadruped to humanoid revenue shows product-market fit, the 52.6% drop in Q1 core profit signals that the 'growth at all costs' phase is hitting margin compression as R&D and marketing expenses balloon. With 13.3% of revenue tied to the U.S. and looming export controls, the valuation assumes perfect execution in a hostile regulatory climate. Investors are essentially paying for a speculative AI-robotics play while ignoring the reality that this company is a prime target for future U.S. entity list restrictions.
If Unitree successfully pivots its supply chain to domestic components and dominates the massive Chinese industrial automation market, the current valuation could look like a bargain compared to Western peers like Boston Dynamics.
"Unitree is priced for flawless execution in a duopoly market (Tesla Optimus, Boston Dynamics) while showing deteriorating unit economics and geopolitical headwinds."
Unitree's $9B valuation on 1.7B yuan revenue (2025) implies 53x sales multiple — stratospheric even for robotics. The IPO timing is clever: list before U.S. restrictions bite, lock in Chinese capital, use proceeds to build moat. DeepSeek's participation signals AI-robotics convergence. But Q1 2026 profit collapsed 52.6% despite 68.5% revenue growth — classic sign of margin compression or unsustainable spending. U.S. sales are only 13.3% of revenue, so geopolitical risk is real but not existential. The real question: can humanoid robots move from demos to profitable unit economics at scale?
A 53x sales multiple assumes Unitree achieves Tesla-like margins (20%+) within 5 years; current trajectory shows the opposite. If U.S. restrictions tighten faster than expected and Chinese demand softens (already slowing in Q1), this valuation craters.
"The IPO valuation is too rich given 2025 revenue, Q1 margin weakness, and outsized US exposure amid geopolitical risks; unless non-US growth and software monetization accelerate, the stock faces downside."
Unitree's STAR Market IPO prices the company at about 61 billion yuan ($9B), signaling confidence in a robotics upcycle. 2025 revenue hits 1.7B yuan, humanoid robot sales 867.8M, and Q1 2026 revenue up 68.5% y/y, but profit ex-items fell 52.6% as it crowds in R&D and marketing. The bear case: U.S. exposure accounted for 13.3% of revenue last year, and policy risks—tariffs, export controls, or loss of approvals—could throttle overseas demand and disrupt parts supply. The valuation implies aggressive software/AI monetization and non-US growth hinges on execution rather than hardware prowess, making the upside contingent on policy and margin expansion.
Against this stance, a stronger bull case would be that non-US demand could accelerate and Unitree could monetize software/AI/services to lift margins, justifying the premium if policy risks don't materialize. Additionally, domestic Chinese demand for robotics and automation could be underappreciated by the market, offsetting export-headwinds.
"Subsidies may embed structural margin ceilings that undermine the re-rating bull case."
Claude's 53x sales multiple claim overstates the froth; using consistent USD conversion it's ~36x trailing. More critically, nobody has flagged that Beijing's subsidies for national champions often come with strings—forced tech sharing or margin caps—that could structurally impair Unitree's path to Tesla-like 20%+ margins everyone keeps citing.
"The valuation hinges on whether DeepSeek integration enables a high-margin software-as-a-service model rather than a hardware-commodity play."
Grok, you're right about the subsidies, but you're all missing the 'DeepSeek' factor. This isn't just hardware; it's a data-moat play. If DeepSeek integrates their LLMs into Unitree’s OS, the software-to-hardware attachment rate could decouple them from traditional robotics margins. Claude, the 53x multiple is irrelevant if they pivot to a SaaS-like model for industrial automation. The real risk isn't just U.S. export curbs—it’s the potential for a 'Great Firewall' of robotics that renders their software incompatible with global standards.
"DeepSeek integration could be a liability, not an asset, if Beijing weaponizes it to cap Unitree's software margins."
Gemini's DeepSeek-as-moat thesis is seductive but unproven. Integrating LLMs into robotics OS doesn't automatically create SaaS defensibility—hardware still commoditizes. More pressing: if Beijing mandates DeepSeek integration as a condition of subsidies, Unitree loses pricing power on software. Grok's point about subsidy strings is underexplored. The real margin risk isn't U.S. curbs; it's forced tech-sharing with state-backed competitors domestically.
"The assumption that DeepSeek creates a durable software moat is unproven; without proven SaaS-like profitability, a 36x+ sales multiple for a hardware-heavy robotics play looks riskier than the discussion implies."
Gemini’s DeepSeek moat idea deserves scrutiny. Even if LLMs improve Unitree’s OS, there’s no proven path to a SaaS-like margin when hardware remains commodity-grade and subsidies may force tech-sharing or price controls. The result could be a hardware-heavy business with distressed margins, not a defensible software moat. Until software monetization scale and profitability are demonstrated, the 36x+ sales multiple looks risky.
The panel is largely bearish on Unitree's IPO, citing a frothy valuation, margin compression, and significant geopolitical risks, despite the potential of AI and software integration.
The potential integration of DeepSeek's LLMs into Unitree's OS, which could decouple them from traditional robotics margins and create a software moat.
Forced tech-sharing or margin caps due to Beijing's subsidies, which could structurally impair Unitree's path to high margins.